Guofang Zhao

机构：Ningbo No. 2 Hospital, Ningbo No.6 Hospital

发表论文 18 篇 · 总被引 349 次 · h-index 8

代表论文

• Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial (2024 · The Lancet Respiratory Medicine · 被引 122)
• Expert consensus on resection of chest wall tumors and chest wall reconstruction (2021 · Translational Lung Cancer Research · 被引 82)
• LncRNA FOXD3-AS1 promoted chemo-resistance of NSCLC cells via directly acting on miR-127-3p/MDM2 axis (2020 · Cancer Cell International · 被引 32)
• International expert consensus on immunotherapy for early-stage non-small cell lung cancer (2022 · Translational Lung Cancer Research · 被引 25)
• ATM inhibitor KU60019 synergistically sensitizes lung cancer cells to topoisomerase II poisons by multiple mechanisms (2023 · Scientific Reports · 被引 20)
• Predicting the risk of lung cancer using machine learning: A large study based on UK Biobank (2024 · Medicine · 被引 16)